Myomo (MYO) FCF Margin Growth (3y) (2019 - 2025)
Myomo (MYO) FCF Margin Growth (3y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 38.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 30.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -310.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 96.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -2,196.00 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2,679.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -20.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -472.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Myomo | 39.24 Mn | 20.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 4,212.00 |
| Jun 30, 2025 | -3,143.00 |
| Mar 31, 2025 | 2,729.00 |
| Dec 31, 2024 | 6,718.00 |
| Sep 30, 2024 | 3,151.00 |
| Jun 30, 2024 | 8,890.00 |
| Mar 31, 2024 | 429.00 |
| Dec 31, 2023 | -1,989.00 |
| Sep 30, 2023 | 5,977.00 |
| Jun 30, 2023 | 42,065.00 |
| Mar 31, 2023 | 18,929.00 |
| Dec 31, 2022 | 11,372.00 |
| Sep 30, 2022 | 30,743.00 |
| Jun 30, 2022 | 18,976.00 |
| Mar 31, 2022 | 31,517.00 |
| Dec 31, 2021 | 23,714.00 |
| Sep 30, 2021 | 36,240.00 |
| Jun 30, 2021 | 25,747.00 |
| Mar 31, 2021 | 65,175.00 |
| Dec 31, 2020 | 26,233.00 |